|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Heat-shock protein 90 inhibitors in cancer therapy : 17AAG and beyond 显示文摘 | Georgakis GV Younes A | 2005 | Future Oncol2005，1，2： | 1 |
| 2 | Inhibition of heat shock protein 90 function by 17-allylamino-17-demethoxy-geldan-amycin in Hodgkin's lymphoma ceils down-regulates Akt kinase,dephosphorylates extracellular signal-regulated kinase,and induces cell cycle arrest and cell death显示文摘 | Georgakis GV Li Y Rassidakis GZ | 2006 | Clin Cancer Res2006，12，2： | 1 |
| 3 | From Rapa Nui to rapamycin:targeting PI3K/Akt/mTOR for cancer therapy显示文摘 | Younes A | 2006 | Expert Rev Anticaneer Ther2006，6，1： | 1 |
| 4 | The HSP90 inhibitor 17- AAG synergizes with doxorubicin and U0126 in anaplastie large cell lymphoma irrespective of ALK expression显示文摘 | Georgakis GV Li Y rassidakis GZ | 2006 | Exp Hematol2006，34，12： | 1 |
| 5 | Inhibition of heat shock protein 90 function by 17-allylamino-17-demethoxy-geldanamycin in Hodgkin's lymphoma cells down-regulates Akt kinase, dephosphorylates extracellular signal-regulated kinase, and induces cell cycle arrest and cell death显示文摘 | Georgakis GV Li Y Rassidakis GZ | 2006 | Clin Cancer Res2006，12，2： | 1 |
| 6 | Inhibition of the phosphatidylinositol-3 kinase/Akt promotes G1 cell cycle arrest and apoptosis in Hodgkin lymphoma显示文摘 | Georgakis GV Li Y Rassidakis GZ | 2006 | Br J Haematol2006，132，4： | 1 |
| 7 | Functionalexpression of TRAIL receptors TRAIL-R1 and TRAIL-R2in esophageal adenocarcinoma显示文摘 | Younes M Georgakis GV Rahmani M | 2006 | Eur J Cancer2006，42，4： | 1 |
| 8 | Heat shock protein 90 inhibitors in cancer therapy:17AAG and beyond显示文摘 | Georgakis GV Younes A | | 0，，： | 1 |
| 9 | The heat shock protein 90 inhibitor 17-AAG induces cell cycle arrest and apoptosis in mantle cell lymphoma cell lines by depleting cyclin D1, Akt, Bid and activating caspase 9 显示文摘 | Georgakis GV Li Y Younes A | 2006 | Br J Haematol2006，135，1： | 1 |
| 10 | Vorinostat inhibits STAT6-mediated TH2 cytokine and TARC production and induces cell death in Hodgkin lymphoma cell lines 显示文摘 | Buglio D Georgakis GV Hanabuchi S | 2008 | Blood2008，112，4： | 1 |
| 11 | Induction of cell cy- cle arrest and apoptosis by the proteasome inhibitor PS-341 in Hodgkin disease cell lines is independent of inhibitor of nuclear factor-kappaB mutations or activation of the CD30, CD40, and RANK receptors 显示文摘 | ZHENG B GEORGAKIS GV LI Y | 2004 | Clin Cancer Res2004，10，9： | 1 |
| 12 | The heat shock protein 90 inhibitor 17-AAG induces cell cycle arrest and apoptosis in mantle celllymphoma cell lines by depleting cyclin D1, Akt,Bid and activating caspase 9 显示文摘 | Georgakis GV Li Y Younes A | 2006 | Br J Haematol2006，135，1： | 1 |
| 13 | Activity of selective fully human agonistic antibodies to the TRAIL death receptors TRAIL-R1 and TRAIL-R2 in primary and cultured lymphoma cells:induction of apoptosis and enhancement of doxorubicin-and bortezomib-induced cell death显示文摘 | Georgakis GV Li Y Humphreys R | 2005 | Br J Haematol2005，130，： | 1 |
| 14 | From Rapa Nui to rapamyein:tar- geting PI3K/Akt/mTOR for cancer therapy显示文摘 | Georgakis GV Younes A | 2006 | Expert Rev An- tieaneer Ther2006，6，1： | 1 |
| 15 | The antileukemia activity of a human anti-CD40 antagonist antibody,HCD122,on human chronic lymphocytic leukemia cells显示文摘 | Luqman M Klabunde S Georgakis GV | 2008 | Blood2008，112，3： | 1 |
| 16 | Inhibition of the phosphati- dylinositol-3 kinase/Akt promotes G1 cell cycle arrest and apoptosis in Hodgkin lymphoma显示文摘 | Georgakis GV Li Y Rassidakis GZ | 2006 | Br J Haematol2006，132，4： | 1 |
| 17 | From Rapa Nui to rapamycin: targeting PI3K/Akt/mTOR for cancer therapy 显示文摘 | Georgakis GV Younes A | 2006 | Expert Rev Anticancer Ther2006，6，1： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员